Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-034055

Director sold 22,000 shares at $5.10 ($112,207)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2025-07-01 Sale 10b5-1 −22,000 $5.10 $112,207 1,298,391 D
Open-market sales · 22,000 sh · avg $5.10 · $112,207
Loading xslF345X05/wk-form4_1751490221.xml…